Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Oncologic Surgery
NCT05823467Terminated
- Sponsor
- University of Alberta
- Start
- Jun 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trimethoprim + sulfamethoxazole in Postoperative wound complications (3 arms), sponsored by University of Alberta. Primary endpoint: Rate of Wound Complication at 14 days. Started Jun 2023; status: terminated.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
Postoperative wound complications
Beyond the preview
Go deeper on NCT05823467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823467.